Rigel Pharmaceuticals Inc
F:RI2A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rigel Pharmaceuticals Inc
F:RI2A
|
US |
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
D
|
DSV A/S
SWB:DS81
|
DK |
|
Spruce Biosciences Inc
OTC:SPRB
|
US |
|
C
|
Celestica Inc
NYSE:CLS
|
CA |
|
V
|
Volvo AB
SWB:VOL3
|
SE |
|
Hon Hai Precision Industry Co Ltd
TWSE:2317
|
TW |
|
D
|
Deutsche Bank AG
XMUN:DBK
|
DE |
|
H
|
Hon Hai Precision Industry Co Ltd
LSE:HHPD
|
TW |
|
GSK plc
F:GS70
|
UK |
|
Fastly Inc
NASDAQ:FSLY
|
US |
|
A
|
Asics Corp
XMUN:ASI1
|
JP |
|
Credit Agricole SA
F:XCAU
|
FR |
|
A
|
Antofagasta PLC
F:FG1
|
UK |
|
MS&AD Insurance Group Holdings Inc
OTC:MSADY
|
JP |
|
T
|
Thales SA
F:CSF
|
FR |
Wall St Price Targets
RI2A Price Targets Summary
Rigel Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RI2A is 14.75 EUR with a low forecast of 10.58 EUR and a high forecast of 22.28 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RI2A's stock price target?
Price Target
14.75
EUR
According to Wall Street analysts, the average 1-year price target for RI2A is 14.75 EUR with a low forecast of 10.58 EUR and a high forecast of 22.28 EUR.
What is the Revenue forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
13%
The compound annual growth rate for Gross Profit over the next 3 years is 13%.
What is the Operating Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
3%
The compound annual growth rate for Operating Income over the next 8 years is 3%.
What is the Pre-Tax Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-2%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -2%.
What is the Net Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-6%
The compound annual growth rate for Net Income over the next 8 years is -6%.
